Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade

Autor:	Rebecca L. Manno, Clifton O. Bingham, Jarushka Naidoo, Patrick M. Forde, Dung T. Le, William H. Sharfman, Ami A. Shah, Jemima Albayda, Evan J. Lipson, Julie R. Brahmer, Anna Kristina Gutierrez, Alan N. Baer, Kristen A. Marrone, Hans J. Hammers, Uzma Haque, Laura C. Cappelli
Rok vydání:	2017
Předmět:	Cancer Research animal diseases Immune checkpoint inhibitors Inflammatory arthritis Programmed Cell Death 1 Receptor Arthritis chemical and pharmacologic phenomena Inflammation Bioinformatics 03 medical and health sciences 0302 clinical medicine medicine Humans Adverse effect 030203 arthritis & rheumatology business.industry biochemical phenomena metabolism and nutrition medicine.disease Immune checkpoint 3. Good health Blockade Oncology 030220 oncology & carcinogenesis Immunology Commentary bacteria medicine.symptom business
Zdroj:	The Oncologist
ISSN:	1549-490X 1083-7159
DOI:	10.1634/theoncologist.2016-0390
Popis:	This commentary summarizes current knowledge on the clinical presentation, management, and outcomes of the inflammatory arthritis which may occur as an immune-related adverse evet of immune checkpoint inhibitor therapy. Herein, we propose a new algorithm aimed at assisting oncologists in the diagnosis and management of this immune-related adverse event.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52c2343bfc9b08aa55e9c5090450fb40 https://doi.org/10.1634/theoncologist.2016-0390 Zobrazit plný text záznamu Plný text